This is a Phase 1 study to measure and compare the levels of the study drug, TP-3654, when given with different drugs. TP-3654 is being developed to treat patients with cancer refractory solid tumors and myelofibrosis).

Frontage Clinical Services prioritizes the safety and well-being of our study participants, our employees, and visitors to our clinic. As such, we have incorporated additional policies and procedures, as recommended by the CDC.

Application for Clinical Research Study

Research StudyThis is a Phase 1 study to measure and compare the levels of the study drug, TP-3654, when given with different drugs. TP-3654 is being developed to treat patients with cancer refractory solid tumors and myelofibrosis).

*First Name

*Last Name

*Date of Birth

*Phone Number:

Email address:

Your information will be used solely for research recruitment purposes by our research team and will not be shared externally. All submissions are stored securely in accordance with HIPAA and Good Clinical Practice (GCP) standards.

Please fill out all required fields.

About our Clinical Research Facility

The Frontage Clinical Research Center in New Jersey is a modern, comfortable facility located within 20 miles of New York City in Secaucus, NJ. It is easily accessible by car, train or bus. There are 160 beds that are arranged in different areas of the facility, which can be further divided for additional privacy. The frontage staff is highly qualified, experienced and friendly and treats all volunteers with respect and compassion.

Printable Version of this Clinical Research Flyer